Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles

被引:45
|
作者
Dupuy, C [1 ]
BuzoniGatel, D [1 ]
Touze, A [1 ]
LeCann, P [1 ]
Bout, D [1 ]
Coursaget, P [1 ]
机构
[1] FAC PHARM TOURS, LAB IMMUNOL MALAD INFECT, F-37200 TOURS, FRANCE
关键词
HPV; cervical cancer; virus-like particles; cell mediated immunity; cytokines; Th1; profile;
D O I
10.1006/mpat.1996.0113
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recombinant human papillomavirus (HPV) type 16 L1 virus-like particles (VLPs) expressed in the baculovirus system were used to investigate the cellular immune response to human papillomavirus type 16. The cell-mediated immune response was evaluated through immunization of mice with HPV 16 L1 virus-like particles using a lymphoproliferation assay and cytokine production and cytometric analysis of lymphocyte subsets. A significant proliferative response was observed which was associated with secretion of both interferon-gamma and interleukin-2. FAGS analysis of splenic lymphocytes revealed that CD8(+) T-cells were increased in the immunized mice. These results demonstrate that HPV 16 L1 VLPs induce a T-cell response characterized by a Th1 profile and confirm that the HPV 16 VLP is a reasonable candidate for vaccine development. (C) 1997 Academic Press Limited.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 50 条
  • [31] Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses
    Hainisch, E. K.
    Brandt, S.
    Shafti-Keramat, S.
    Van Den Hoven, R.
    Kirnbauer, R.
    EQUINE VETERINARY JOURNAL, 2012, 44 (01) : 107 - 111
  • [32] Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles
    Liu, Cunbao
    Yao, Yufeng
    Yang, Xu
    Bai, Hongmei
    Huang, Weiwei
    Xia, Ye
    Ma, Yanbing
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 25 (06) : 936 - 940
  • [33] Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies
    Rose, RC
    Lane, C
    Wilson, S
    Suzich, JA
    Rybicki, E
    Williamson, AL
    VACCINE, 1999, 17 (17) : 2129 - 2135
  • [34] HPV vaccines. Prophylactic vaccines from virus-like particles
    Kirnbauer, R.
    HAUTARZT, 2007, 58 (06): : 489 - 492
  • [35] Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein
    Di Bonito, Paola
    Grasso, Felicia
    Mochi, Stefania
    Petrone, Linda
    Fanales-Belasio, Emanuele
    Mei, Arianna
    Cesolini, Armando
    Laconi, Giuseppe
    Conrad, Heinke
    Bernhard, Helga
    Dembek, Claudia J.
    Cosma, Antonio
    Santini, Stefano M.
    Lapenta, Caterina
    Donati, Simona
    Muratori, Claudia
    Giorgi, Colomba
    Federico, Maurizio
    VIROLOGY, 2009, 395 (01) : 45 - 55
  • [36] Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles
    Tachezy, R
    Hamsikova, E
    Hajek, T
    Mikyskova, I
    Smahel, M
    Van Ranst, M
    Kanka, J
    Havrankova, A
    Rob, L
    Guttner, V
    Slavik, V
    Anton, M
    Kratochvil, B
    Kotrsova, L
    Vonka, V
    JOURNAL OF MEDICAL VIROLOGY, 1999, 58 (04) : 378 - 386
  • [37] Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
    Chen, Chun-Wei
    Saubi, Narcis
    Kilpelainen, Athina
    Joseph-Munne, Joan
    VACCINES, 2023, 11 (01)
  • [38] Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic
    Millan, Alicia Fernandez-San
    Ortigosa, Susana M.
    Hervas-Stubbs, Sandra
    Corral-Martinez, Patricia
    Segui-Simarro, Jose M.
    Gaetan, Julien
    Coursaget, Pierre
    Veramendi, Jon
    PLANT BIOTECHNOLOGY JOURNAL, 2008, 6 (05) : 427 - 441
  • [39] Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic
    Chen, Yumei
    Liu, Yunchao
    Zhang, Gaiping
    Wang, Aiping
    Dong, Ziming
    Qi, Yanhua
    Wang, Jucai
    Zhao, Baolei
    Li, Ning
    Jiang, Min
    VIRUS RESEARCH, 2016, 220 : 97 - 103
  • [40] HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer
    Namvar, A.
    Bolhassani, A.
    Hashemi, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (03): : 179 - 184